Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-07 4:31 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | Legion Partners Asset Management LLC | 6,462,604 16.600% | 1,500,790 (+30.25%) | View |
| 2024-07-05 2:17 pm Unchanged | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 5,007,666 16.000% | 0 (Unchanged) | View |
| 2024-07-01 4:43 pm Unchanged | 13D | LIFECORE BIOMEDICAL INC. LFCR | 22NW Fund LP | 4,103,221 12.400% | 0 (Unchanged) | View |
| 2024-07-01 4:05 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | Legion Partners Asset Management LLC | 4,961,814 15.200% | 90,883 (+1.87%) | View |
| 2024-06-11 5:27 pm Unchanged | 13D | LIFECORE BIOMEDICAL INC. LFCR | 22NW Fund LP | 4,103,221 12.500% | 0 (Unchanged) | View |
| 2024-05-20 4:32 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | 22NW Fund LP | 4,103,221 12.500% | 43,216 (+1.06%) | View |
| 2024-02-29 4:25 pm Unchanged | 13D | LIFECORE BIOMEDICAL INC. LFCR | 22NW Fund LP | 4,060,005 12.440% | 0 (Unchanged) | View |
| 2024-02-09 09:59 am Sale | 13G | LIFECORE BIOMEDICAL INC. LFCR | DIMENSIONAL FUND ADVISORS LP | 1,940 0.000% | -1,755,604 (-99.89%) | View |
| 2024-01-04 4:00 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | Legion Partners Asset Management LLC | 4,870,931 15.100% | 1,904,391 (+64.20%) | View |
| 2023-08-15 5:07 pm Sale | 13D | LIFECORE BIOMEDICAL INC. LFCR | Cove Street Capital LLC | 1,583,440 5.150% | -791,325 (-33.32%) | View |
| 2023-07-07 4:35 pm Sale | 13G | LIFECORE BIOMEDICAL INC. LFCR | BlackRock Inc. BLK | 532,043 1.800% | -1,316,110 (-71.21%) | View |
| 2023-06-30 2:46 pm Purchase | 13G | LIFECORE BIOMEDICAL INC. LFCR | Greenhaven Road Investment Management L.P. | 1,902,639 6.300% | 1,902,639 (New Position) | View |
| 2023-06-28 4:32 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | 22NW Fund LP | 3,169,937 9.990% | 73,150 (+2.36%) | View |
| 2023-03-16 4:15 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,926,795 16.600% | 464,285 (+10.40%) | View |
| 2023-03-07 4:25 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 5,387,830 17.900% | 461,035 (+9.36%) | View |
| 2023-02-14 4:16 pm Sale | 13G | LIFECORE BIOMEDICAL INC. LFCR | ISZO CAPITAL LP | 373,778 1.300% | -1,551,533 (-80.59%) | View |
| 2023-02-10 2:42 pm Sale | 13G | LIFECORE BIOMEDICAL INC. LFCR | DIMENSIONAL FUND ADVISORS LP | 1,757,544 5.900% | -216,064 (-10.95%) | View |
| 2023-02-01 4:54 pm Sale | 13G | LIFECORE BIOMEDICAL INC. LFCR | BlackRock Inc. BLK | 1,848,153 6.200% | -98,305 (-5.05%) | View |
| 2023-01-12 5:13 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 4,926,795 16.600% | 2,362,271 (+92.11%) | View |
| 2023-01-12 4:23 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | Cove Street Capital LLC | 2,374,765 7.890% | 578,401 (+32.20%) | View |